Comparative cost effectiveness of Coflex® interlaminar stabilization versus instrumented posterolateral lumbar fusion for the treatment of lumbar spinal stenosis and spondylolisthesis
Open Access
- 1 March 2014
- journal article
- Published by Taylor & Francis in ClinicoEconomics and Outcomes Research
- Vol. 6, 125-31
Abstract
Introduction: Symptomatic chronic low back and leg pain resulting from lumbar spinal stenosis is expensive to treat and manage. A randomized, controlled, multicenter US Food and Drug Administration Investigational Device Exemption clinical trial assessed treatment-related patient outcomes comparing the Coflex® Interlaminar Stabilization Device, an interlaminar stabilization implant inserted following decompressive surgical laminotomy in the lumbar spine, to instrumented posterolateral fusion among patients with moderate to severe spinal stenosis. This study uses patient-reported outcomes and clinical events from the trial along with costs and expected resource utilization to determine cost effectiveness. Methods: A decision-analytic model compared outcomes over 5 years. Clinical input parameters were derived from the trial. Oswestry Disability Index scores were converted to utilities. Treatment patterns over 5 years were estimated based on claims analyses and expert opinion. A third-party payer perspective was used; costs (in $US 2013) and outcomes were discounted at 3% annually. Sensitivity analyses examined the influence of key parameters. Analyses were conducted using Medicare payment rates and typical commercial reimbursements. Results: Five-year costs were lower for patients implanted with Coflex compared to those undergoing fusion. Average Medicare payments over 5 years were estimated at $15,182 for Coflex compared to $26,863 for the fusion control, a difference of $11,681. Mean quality-adjusted life years were higher for Coflex patients compared to controls (3.02 vs 2.97). Results indicate that patients implanted with the Coflex device derive more utility, on average, than those treated with fusion, but at substantially lower costs. The cost advantage was greater when evaluating commercial insurance payments. Subgroup analyses found that the cost advantage for Coflex relative to fusion was even larger for two-level procedures compared to one-level procedures. Conclusion: The Coflex Interlaminar Stabilization Device was found to be cost effective compared to instrumented posterolateral fusion for treatment of lumbar spinal stenosis. It provided higher utility at substantially lower cost.Keywords
This publication has 13 references indexed in Scilit:
- Can low-grade spondylolisthesis be effectively treated by either coflex interlaminar stabilization or laminectomy and posterior spinal fusion? Two-year clinical and radiographic results from the randomized, prospective, multicenter US investigational device exemption trialJournal of Neurosurgery: Spine, 2013
- Decompression and Coflex Interlaminar Stabilization Compared With Decompression and Instrumented Spinal Fusion for Spinal Stenosis and Low-Grade Degenerative SpondylolisthesisSpine, 2013
- Comparative Effectiveness Evidence From the Spine Patient Outcomes Research TrialSpine, 2011
- Surgical treatment patterns among Medicare beneficiaries newly diagnosed with lumbar spinal stenosisThe Spine Journal, 2010
- Trends, Major Medical Complications, and Charges Associated With Surgery for Lumbar Spinal Stenosis in Older AdultsJAMA, 2010
- Spinal stenosis prevalence and association with symptoms: the Framingham StudyThe Spine Journal, 2009
- Interspinous Process Devices in the Lumbar SpineJournal of Spinal Disorders & Techniques, 2007
- The Oswestry Disability IndexSpine, 2000
- Cost-Effectiveness of Fusion With and Without Instrumentation for Patients With Degenerative Spondylolisthesis and Spinal StenosisSpine, 2000
- Lumbar Laminectomy Alone or With Instrumented or Noninstrumented Arthrodesis in Degenerative Lumbar Spinal StenosisSpine, 1997